Holen Sie sich die Stockscreener-App
6.45
0.15%
-0.010
Handel nachbörslich:
6.49
0.04
+0.62%
Aquestive Therapeutics Inc Aktie (AQST) Neueste Nachrichten
Aquestive completes marketing application for Anaphylm in U.S. - MSN
Aquestive Therapeutics Stock Dips After-Hours On Q4 Miss — Retail Eyes Silver Linings - MSN
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Aquestive Therapeutics (NASDAQ:AQST) Shares Up 5.7%Should You Buy? - MarketBeat
Aquestive Therapeutics, Inc.(NasdaqGM:AQST) added to S&P Pharmaceuticals Select Industry Index - marketscreener.com
Aquestive Therapeutics (NASDAQ:AQST) shareholders are still up 524% over 3 years despite pulling back 6.6% in the past week - simplywall.st
Is Aquestive Therapeutics Inc. stock gaining market shareWeekly Earnings Recap & Growth Focused Entry Point Reports - Улправда
Is Aquestive Therapeutics Inc. stock a buy on dips2025 Valuation Update & Entry Point Confirmation Signals - Улправда
How rising interest rates impact Aquestive Therapeutics Inc. stock2025 Retail Activity & Long-Term Growth Portfolio Plans - Улправда
Published on: 2025-12-19 18:44:27 - DonanımHaber
How Aquestive Therapeutics Inc. stock benefits from tech adoption2025 Growth vs Value & Accurate Intraday Trade Tips - DonanımHaber
What dividend safety score for Aquestive Therapeutics Inc. stockJuly 2025 News Drivers & Scalable Portfolio Growth Methods - DonanımHaber
Is Aquestive Therapeutics Inc. stock positioned for digital transformation2025 Buyback Activity & Expert Curated Trade Setups - ulpravda.ru
Aquestive Therapeutics Earnings Notes - Trefis
Aquestive Therapeutics (NASDAQ:AQST) Trading Down 4.6%What's Next? - MarketBeat
Is Aquestive Therapeutics Stock Built to Withstand a Pullback? - Trefis
Pale Fire Capital SE Acquires 340,767 Shares of Aquestive Therapeutics, Inc. $AQST - MarketBeat
Looking at the Narrative for Aquestive Therapeutics After New Anaphylm Patents and FDA Momentum - Yahoo Finance
Aquestive Therapeutics Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Published on: 2025-12-08 02:09:31 - BỘ NỘI VỤ
Diametric Capital LP Acquires Shares of 165,373 Aquestive Therapeutics, Inc. $AQST - MarketBeat
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
What analyst consensus says on Aquestive Therapeutics Inc. stockJuly 2025 Intraday Action & Daily Profit Focused Screening - Newser
VP Cioffi Surrenders 2,083 Of Aquestive Therapeutics Inc [AQST] - TradingView
Sio Capital Management LLC Buys 555,860 Shares of Aquestive Therapeutics, Inc. $AQST - MarketBeat
Published on: 2025-12-03 04:52:42 - Newser
Aquestive Therapeutics (AQST) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Everstar Asset Management LLC Raises Holdings in Aquestive Therapeutics, Inc. $AQST - MarketBeat
Quarterly Trades: Why Aquestive Therapeutics Inc. stock could see breakout soon - BỘ NỘI VỤ
Returns Recap: Why Aquestive Therapeutics Inc. stock could see breakout soonPrice Action & Capital Efficiency Focused Ideas - moha.gov.vn
What technical charts say about Aquestive Therapeutics Inc. stockWeekly Investment Summary & Weekly Stock Breakout Alerts - BỘ NỘI VỤ
Aquestive Therapeutics (NASDAQ:AQST) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Aquestive’s Anaphylm Shows Positive Results in First Study in Kids - Allergic Living
Aquestive Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - The Manila Times
How Recent Regulatory Wins Are Shaping the Narrative for Aquestive Therapeutics - Yahoo Finance
Aquestive Therapeutics Shares Rise After $75 Million Funding Deal - MSN
Why Aquestive Therapeutics Inc. stock is favored by top institutionsTrade Volume Summary & Advanced Technical Analysis Signals - newser.com
How to monitor Aquestive Therapeutics Inc. with trend dashboardsEarnings Risk Report & High Return Stock Watch Alerts - newser.com
Can Aquestive Therapeutics Inc. stock sustain revenue growthPortfolio Profit Report & Real-Time Volume Trigger Notifications - newser.com
Why Aquestive Therapeutics Inc. stock is trending among retail tradersMarket Performance Summary & Proven Capital Preservation Tips - newser.com
Why Aquestive Therapeutics Inc. stock could outperform in 2025July 2025 Opening Moves & Technical Buy Zone Confirmations - newser.com
Aquestive Therapeutics (AQST) Price Target Increased by 14.80% to 10.51 - MSN
Aquestive Therapeutics Inc. stock momentum explainedMarket Rally & High Accuracy Trade Signal Alerts - newser.com
Risk vs reward if holding onto Aquestive Therapeutics Inc.Swing Trade & Real-Time Market Sentiment Reports - newser.com
Aquestive Therapeutics (NASDAQ:AQST) Trading Up 6.5%Here's Why - MarketBeat
Officer Kraus Files To Sell 53,100 Of Aquestive Therapeutics Inc [AQST] - TradingView
Will Aquestive Therapeutics Inc. bounce back from current supportLayoff News & AI Based Buy and Sell Signals - newser.com
Can trapped investors hope for a rebound in Aquestive Therapeutics Inc.Analyst Upgrade & Daily Oversold Stock Bounce Ideas - newser.com
Predicting Aquestive Therapeutics Inc. trend using moving averagesJuly 2025 Short Interest & Low Risk High Reward Ideas - newser.com
Aquestive Therapeutics’ Earnings Call: Optimism Amid Challenges - MSN
Aquestive Therapeutics (NASDAQ:AQST) Updates Amid Dow Jones Industrial Average - Kalkine Media
2.19%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):